These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33148855)

  • 21. Drug-induced renal calculi: epidemiology, prevention and management.
    Daudon M; Jungers P
    Drugs; 2004; 64(3):245-75. PubMed ID: 14871169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the general practictioner in the management of urinary calculi.
    Prezioso D; Piccinocchi G; Abate V; Ancona M; Celia A; De Luca C; Ferrari R; Ferraro PM; Mancon S; Mazzon G; Micali S; Puca G; Rendina D; Saita A; Salvetti A; Spasiano A; Tesè E; Trinchieri A
    Arch Ital Urol Androl; 2023 Dec; 95(4):12155. PubMed ID: 38193217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The elementome of calcium-based urinary stones and its role in urolithiasis.
    Ramaswamy K; Killilea DW; Kapahi P; Kahn AJ; Chi T; Stoller ML
    Nat Rev Urol; 2015 Oct; 12(10):543-57. PubMed ID: 26334088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of definition category of complexity of urinary stones in the systematization of complications of endosopic surgery of urolitiasis].
    Giyasov SI; Akilov FA; Mukhtarov ST; Abdurashidov AA; Azimov ET
    Urologiia; 2020 Mar; (1):39-45. PubMed ID: 32195555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical analysis of urolithiasis in Poh Ai Hospital of I-Lan, Taiwan, R.O.C.--a comparative study with urolithiasis in Japan].
    Lin FS; Wang SS; Hsieh TS; Chen J; Tsai TC; Hsu TC; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1992 Dec; 38(12):1349-55. PubMed ID: 1288222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dual-energy computed tomography in the diagnostics of urolithiasis].
    Kapanadze LB; Rudenko VI; Serova NS; Rapoport LM; Aleksandrova KA; Novikov AA
    Urologiia; 2019 Dec; (5):31-36. PubMed ID: 31808629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Characteristics of pathogenesis and manifestations of nephrolithiasis in patients with chronic cardiovascular diseases].
    Yarovoy SK; Royuk RV
    Urologiia; 2021 Jun; (3):33-38. PubMed ID: 34251098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic Work-up of Patients with Urolithiasis: Indications and Diagnostic Algorithm.
    Tiselius HG; Daudon M; Thomas K; Seitz C
    Eur Urol Focus; 2017 Feb; 3(1):62-71. PubMed ID: 28720369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.
    Daudon M; Frochot V; Bazin D; Jungers P
    Drugs; 2018 Feb; 78(2):163-201. PubMed ID: 29264783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulfamethoxazole-induced sulfamethoxazole urolithiasis: a case report.
    Roedel MM; Nakada SY; Penniston KL
    BMC Urol; 2021 Sep; 21(1):133. PubMed ID: 34535099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antioxidative activity and clinical efficiency of dietary supplements Nefradoz for treatment of recurrent calcium oxalate urolithiasis].
    Kamalov AA; Okhobotov DA; Proskurnina EV; Sozarukova MM; Nizov AN
    Urologiia; 2018 Dec; (6):52-59. PubMed ID: 30742378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical outcome of percutaneous nephrolithotripsy and recurrence of stones].
    Nakajima H; Tanda H; Kato S; Ohnishi S; Ujiie T; Nanbu A; Ando T
    Hinyokika Kiyo; 1997 Aug; 43(8):549-53. PubMed ID: 9310776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Time to recurrence after complete removal of calculi from different parts of the urinary system. five-year follow-up study].
    Kutluev MM; Safiullin RI; Mochalov KS
    Urologiia; 2018 Mar; (1):20-24. PubMed ID: 29634129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interdisciplinary approach for prevention of recurrent urinary stone disease].
    Saenko VS; Pesegov SV
    Urologiia; 2020 Nov; (5):87-92. PubMed ID: 33185354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do dental calculi predict the presence of renal stones?
    Kati B; Kalkan E; Pelit ES; Yagmur I; Çiftçi H
    Arch Ital Urol Androl; 2018 Sep; 90(3):159-162. PubMed ID: 30362677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is idiopathic recurrent calcium urolithiasis in males a cellular disease? Laboratory findings in plasma, urine and erythrocytes, emphasizing the absence and presence of stones, oxidative and mineral metabolism: an observational study.
    Schwille PO; Manoharan M; Schmiedl A
    Clin Chem Lab Med; 2005; 43(6):590-600. PubMed ID: 16006254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical Treatment and Prevention of Urinary Stone Disease.
    Spradling K; Ganesan C; Conti S
    Urol Clin North Am; 2022 May; 49(2):335-344. PubMed ID: 35428438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric urolithiasis--evaluation of risk factors in 95 children.
    Erbagci A; Erbagci AB; Yilmaz M; Yagci F; Tarakcioglu M; Yurtseven C; Koyluoglu O; Sarica K
    Scand J Urol Nephrol; 2003; 37(2):129-33. PubMed ID: 12745721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxalates, urinary stones and risk of cardiovascular diseases.
    Arafa A; Eshak ES; Iso H
    Med Hypotheses; 2020 Apr; 137():109570. PubMed ID: 31972450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.